Explore the full record of transactions filed by Joakim Tedroff, Membre du Conseil. Officer active across 2 companies, notably IRLAB Therapeutics AB. Cumulatively, 4 disclosures have been recorded. Activity tracked since 17 July 2025. The latest transaction was filed on 28 November 2025 (Purchase). Regulator: FIN-FSA. The full history is openly available.
116,196 shares@ €0.30960.033% mcap24.5% of flowBTA (betald tecknad aktie)FI:A003Q787-1
Ideal exit: 13 Apr 2026 (T+270)
4 of 4 declarations
About Joakim Tedroff
Joakim Tedroff is a board member of IRLAB Therapeutics AB. He brings valuable expertise in corporate governance and strategy. His role involves contributing to strategic decisions and overseeing the company's management. Joakim is committed to ensuring transparency and accountability within the organization.